Sanofi Accused Of Fraud In Clinical Trial Of Drug

Law360, New York (February 15, 2008, 12:00 AM EST) -- Allegations that Sanofi-Aventis Pharmaceuticals deliberately concealed potential harmful effects of its antibiotic Ketek, which has been linked to liver damage, continued to pile up Tuesday as the U.S. House Committee on Energy and Commerce heard more witnesses.

Ana Marie Cisneros, a clinical research associate who worked for one of the doctors contracted by Sanofi to run tests, said that her supervisor and Sanofi worked together to defraud the U.S. Food and Drug Administration by fabricating patients in a 400-person study.

Cisneros said that while working for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.